• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中性粒细胞与淋巴细胞比值升高可预测接受直接经皮冠状动脉介入治疗的ST段抬高型心肌梗死患者的手术不良事件。

Elevated neutrophil-to-lymphocyte ratio can predict procedural adverse events in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention.

作者信息

Pinheiro Machado Guilherme, Araujo Gustavo N, Carpes Christian K, Lech Mateus C, Mariani Stefani, Valle Felipe H, Bergoli Luiz C C, Wainstein Rodrigo V, Wainstein Marco V

机构信息

Department of Cardiology, School of Medicine, Federal University of Rio Grande do Sul.

Department of Cardiology, Cardiology Division, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil.

出版信息

Coron Artery Dis. 2019 Jan;30(1):20-25. doi: 10.1097/MCA.0000000000000671.

DOI:10.1097/MCA.0000000000000671
PMID:30334819
Abstract

BACKGROUND

Elevated neutrophil-to-lymphocyte ratio (NLR) is an indirect marker of inflammation, and is associated with adverse clinical outcomes in patients with ST-segment elevation myocardial infarction (STEMI). The aim of this study was to investigate the usefulness of NLR to predict procedural adverse events is patients who underwent primary percutaneous coronary intervention (PCI).

PATIENTS AND METHODS

Consecutive patients with STEMI who underwent primary PCI were divided into low and high NLR, whereas high was defined as an NLR value above 75° percentile (≥9.45). The occurrence of procedural complications, in-hospital, and 30-day major adverse cardiovascular events and 1-year all-cause mortality were evaluated.

RESULTS

We included 664 patients with a mean age of 60.5 (±12.1) years and 66.3% were male. In multivariate analysis, NLR remained an independent predictor of in-hospital death [relative risk (RR)=1.03; 95% confidence interval (CI)=1.00-1.08; P=0.04], contrast-induced nephropathy (RR=2.35; 95% CI=1.11-4.71; P=0.02), distal embolization (RR=2.72; 95% CI=1.55-4.75; P<0.001), and no-reflow (RR=2.31; 95% CI=2.31-4.68; P=0.01). The area under the curve for distal embolization was 0.67, 0.64 for no-reflow and 0.62 for procedural complications. A low value of NLR had an excellent negative predictive value of 97.8, 96.9, and 92.1 for distal embolization, no-reflow, and procedural complications, respectively.

CONCLUSION

High NLR is an independent predictor of distal embolization, no-reflow, and procedural complications in patients with STEMI who underwent primary PCI. A low NLR value has an excellent negative predictive value for these procedural outcomes. NLR may be a useful and inexpensive tool that may be used at bedside.

摘要

背景

中性粒细胞与淋巴细胞比值(NLR)升高是炎症的间接标志物,与ST段抬高型心肌梗死(STEMI)患者的不良临床结局相关。本研究的目的是探讨NLR对接受直接经皮冠状动脉介入治疗(PCI)患者手术不良事件的预测价值。

患者与方法

连续入选接受直接PCI的STEMI患者,分为低NLR组和高NLR组,高NLR定义为高于第75百分位数(≥9.45)。评估手术并发症、住院期间及30天主要不良心血管事件和1年全因死亡率的发生情况。

结果

我们纳入了664例患者,平均年龄60.5(±12.1)岁,66.3%为男性。多因素分析显示,NLR仍然是住院死亡[相对危险度(RR)=1.03;95%置信区间(CI)=1.00-1.08;P=0.04]、造影剂肾病(RR=2.35;95%CI=1.11-4.71;P=0.02)、远端栓塞(RR=2.72;95%CI=1.55-4.75;P<0.001)和无复流(RR=2.31;95%CI=2.31-4.68;P=0.01)的独立预测因素。远端栓塞的曲线下面积为0.67,无复流为0.64,手术并发症为0.62。低NLR值对远端栓塞、无复流和手术并发症的阴性预测值分别为97.8、96.9和92.1。

结论

高NLR是接受直接PCI的STEMI患者远端栓塞、无复流和手术并发症的独立预测因素。低NLR值对这些手术结局具有良好的阴性预测价值。NLR可能是一种有用且廉价的工具,可在床边使用。

相似文献

1
Elevated neutrophil-to-lymphocyte ratio can predict procedural adverse events in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention.中性粒细胞与淋巴细胞比值升高可预测接受直接经皮冠状动脉介入治疗的ST段抬高型心肌梗死患者的手术不良事件。
Coron Artery Dis. 2019 Jan;30(1):20-25. doi: 10.1097/MCA.0000000000000671.
2
Comparison of neutrophil-to-lymphocyte ratio and mean platelet volume in the prediction of adverse events after primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction.中性粒细胞与淋巴细胞比值和血小板平均体积在预测 ST 段抬高型心肌梗死患者经皮冠状动脉介入治疗后不良事件中的比较。
Atherosclerosis. 2018 Jul;274:212-217. doi: 10.1016/j.atherosclerosis.2018.05.022. Epub 2018 May 17.
3
Predictive value of neutrophil to lymphocyte ratio in patients with acute ST segment elevation myocardial infarction after percutaneous coronary intervention: a meta-analysis.中性粒细胞与淋巴细胞比值对急性ST段抬高型心肌梗死患者经皮冠状动脉介入治疗后的预测价值:一项荟萃分析
BMC Cardiovasc Disord. 2018 May 2;18(1):75. doi: 10.1186/s12872-018-0812-6.
4
Predictive value of admission red cell distribution width-platelet ratio for no-reflow phenomenon in acute ST segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.入院时红细胞分布宽度-血小板比值对接受直接经皮冠状动脉介入治疗的急性ST段抬高型心肌梗死患者无复流现象的预测价值
Cardiol J. 2016;23(1):84-92. doi: 10.5603/CJ.a2015.0070. Epub 2015 Oct 27.
5
Usefulness of Mean Platelet Volume-to-Lymphocyte Ratio for Predicting Angiographic No-Reflow and Short-Term Prognosis After Primary Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction.平均血小板体积与淋巴细胞比值对预测ST段抬高型心肌梗死患者直接经皮冠状动脉介入治疗后血管造影无复流及短期预后的价值
Am J Cardiol. 2017 Aug 15;120(4):534-541. doi: 10.1016/j.amjcard.2017.05.020. Epub 2017 May 30.
6
Prognostic Value of Pre-Infarction Angina Combined with Mean Platelet Volume to Lymphocyte Count Ratio for No-Reflow and Short-Term Mortality in Patients with ST-Segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention.梗死后心绞痛联合血小板平均体积与淋巴细胞计数比值对行经皮冠状动脉介入治疗的 ST 段抬高型心肌梗死患者无复流和短期死亡率的预测价值。
Med Sci Monit. 2020 Jan 7;26:e919300. doi: 10.12659/MSM.919300.
7
Relation of neutrophil/lymphocyte ratio to coronary flow to in-hospital major adverse cardiac events in patients with ST-elevated myocardial infarction undergoing primary coronary intervention.中性粒细胞/淋巴细胞比值与 ST 段抬高型心肌梗死患者行直接经皮冠状动脉介入治疗后住院期间主要不良心脏事件的关系。
Am J Cardiol. 2012 Sep 1;110(5):621-7. doi: 10.1016/j.amjcard.2012.04.041. Epub 2012 May 18.
8
Vitamin D level predicts angiographic no-reflow phenomenon after percutaneous coronary intervention in patients with ST segment elevation myocardial infarction.维生素 D 水平可预测 ST 段抬高型心肌梗死患者经皮冠状动脉介入治疗后的无复流现象。
Biomark Med. 2021 Oct;15(15):1357-1366. doi: 10.2217/bmm-2020-0689. Epub 2021 Sep 17.
9
The combination of neutrophil-to-lymphocyte ratio and platelet correlation parameters in predicting the no-reflow phenomenon after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction.中性粒细胞与淋巴细胞比值及血小板相关参数联合预测 ST 段抬高型心肌梗死患者直接经皮冠状动脉介入治疗后无复流现象。
Scand Cardiovasc J. 2020 Dec;54(6):352-357. doi: 10.1080/14017431.2020.1783457. Epub 2020 Jun 29.
10
Plasma apelin-12 levels may predict in-hospital major adverse cardiac events in ST-elevation myocardial infarction and the relationship between apelin-12 and the neutrophil/lymphocyte ratio in patients undergoing primary coronary intervention.血浆apelin-12水平可能预测ST段抬高型心肌梗死患者住院期间的主要不良心脏事件以及接受直接冠状动脉介入治疗患者中apelin-12与中性粒细胞/淋巴细胞比值之间的关系。
Perfusion. 2017 Apr;32(3):206-213. doi: 10.1177/0267659116676335. Epub 2016 Oct 22.

引用本文的文献

1
A case-control study of the interaction of the eNOS gene polymorphisms rs1799983 and rs1800780 with acute coronary syndrome (ACS) risk factors.一项关于内皮型一氧化氮合酶(eNOS)基因多态性rs1799983和rs1800780与急性冠状动脉综合征(ACS)危险因素相互作用的病例对照研究。
BMC Cardiovasc Disord. 2025 Jul 3;25(1):446. doi: 10.1186/s12872-025-04891-6.
2
Association between inflammation indicators (MLR, NLR, SII, SIRI, and AISI) and erectile dysfunction in US adults: NHANES 2001-2004.美国成年人中炎症指标(MLR、NLR、SII、SIRI 和 AISI)与勃起功能障碍的相关性:NHANES 2001-2004。
J Health Popul Nutr. 2024 Oct 26;43(1):169. doi: 10.1186/s41043-024-00667-4.
3
The Prognostic Role of the Neutrophil-to-Lymphocytes Ratio in the Most Frequent Cardiovascular Diseases: An Update.
中性粒细胞与淋巴细胞比值在最常见心血管疾病中的预后作用:最新进展
Life (Basel). 2024 Aug 7;14(8):985. doi: 10.3390/life14080985.
4
Effect of Elevated Neutrophil-to-Lymphocyte Ratio on Adverse Outcomes in Patients With Myocardial Infarction: A Systematic Review and Meta-Analysis.中性粒细胞与淋巴细胞比值升高对心肌梗死患者不良结局的影响:一项系统评价和荟萃分析
Cureus. 2024 Jun 4;16(6):e61647. doi: 10.7759/cureus.61647. eCollection 2024 Jun.
5
Neutrophil to lymphocyte ratio as a prognostic marker for cardiovascular outcomes in patients with ST-segment elevation myocardial infarction after percutaneous coronary intervention: A systematic review and meta-analysis.中性粒细胞与淋巴细胞比值作为经皮冠状动脉介入治疗后 ST 段抬高型心肌梗死患者心血管结局的预后标志物:系统评价和荟萃分析。
Medicine (Baltimore). 2024 Jun 28;103(26):e38692. doi: 10.1097/MD.0000000000038692.
6
Prognostic impact of monocyte-to-lymphocyte ratio in coronary heart disease: a systematic review and meta-analysis.单核细胞与淋巴细胞比值对冠心病预后的影响:系统评价和荟萃分析。
J Int Med Res. 2023 Oct;51(10):3000605231204469. doi: 10.1177/03000605231204469.
7
Impact of the SGLT2-inhibitor empagliflozin on inflammatory biomarkers after acute myocardial infarction - a post-hoc analysis of the EMMY trial.钠-葡萄糖协同转运蛋白 2 抑制剂恩格列净对急性心肌梗死后炎症生物标志物的影响——EMMY 试验的事后分析。
Cardiovasc Diabetol. 2023 Jul 5;22(1):166. doi: 10.1186/s12933-023-01904-6.
8
The Relationship Between the Neutrophil to Lymphocyte Ratio, The Platelet to Lymphocyte Ratio, and Cardiac Syndrome X.中性粒细胞与淋巴细胞比值、血小板与淋巴细胞比值与X综合征之间的关系
Risk Manag Healthc Policy. 2022 Mar 9;15:427-433. doi: 10.2147/RMHP.S359733. eCollection 2022.
9
Early vs. Late Neutrophil-To-Lymphocyte Ratio for the Prediction of Adverse Outcomes in Patients with STEMI Undergoing Primary PCI.早期与晚期中性粒细胞与淋巴细胞比值对接受直接PCI的ST段抬高型心肌梗死患者不良结局的预测作用
Arq Bras Cardiol. 2021 Mar;116(3):504-506. doi: 10.36660/abc.20200327.
10
Prognostic value of peripheral blood inflammatory cell subsets in patients with acute coronary syndrome undergoing percutaneous coronary intervention.接受经皮冠状动脉介入治疗的急性冠状动脉综合征患者外周血炎症细胞亚群的预后价值
J Int Med Res. 2021 Apr;49(4):3000605211010059. doi: 10.1177/03000605211010059.